Anhui Palo Alto Pharmaceuticals, Inc.
Clinical trials sponsored by Anhui Palo Alto Pharmaceuticals, Inc., explained in plain language.
-
New asthma inhaler shows promise in early trial
Disease control Recruiting nowThis study tests a new corticosteroid inhaler called PA9159 in 60 adults with asthma. Participants receive one of three doses or a placebo for 28 days. The main goal is to see if the drug improves lung function, measured by how much air they can exhale in one second. The trial is…
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New asthma inhaler shows promise in early trial
Disease control Recruiting nowThis study tests a new asthma inhaler called PA9159 in 30 adults with asthma. The goal is to see if it improves lung function and is safe over 4 weeks. Participants will use the inhaler and have their breathing measured regularly.
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC